Dexcom Moves Quickly To Tango With Medtronic In Next-Gen Glucose Testing

Eager to hasten adoption of its second-to-market STS continuous glucose monitoring system, DexCom plans to embark any day on a nationwide launch of the just-approved device

More from Archive

More from Medtech Insight